MRNA vs USCB · rev $145.0M vs P/E 13, rev $145.5M
Moderna Inc (MRNA) versus US Century Bank (USCB) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
US Century Bank (USCB) is a banks - regional company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported USCB revenue for 2025-12-31 was $145.5M. Net income was $26.1M. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. USCB currently screens at market cap $356.5M and trailing P/E 13.3.
MRNA currently screens at market cap $24.52B. USCB currently screens at market cap $356.5M and trailing P/E 13.3.
Not investment advice. Open the MRNA and USCB stock pages for the full models.
Not investment advice.